Ziopharm Sponsored Study Titled 'HLA Typing and Tumor Neoantigen Identification for a Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors' Posted To ClinicalTrials.gov; Study Is Recruiting